Financials
- Market Capitalization 7.26 M
- Employee 23
- Founded 2015
- CEO N/A
- Website www.boltbio.com
- Headquarter Delaware, United States
- FIGI BBG00N8MY5V9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4882 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 5.97 USD | -0.67% | +1.02% | +18.45% | +282.69% | 7.73 M USD | ||
| 4887 | CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.09 USD | -1.55% | +4.95% | +6.26% | +485.06% | 7.44 M USD | ||
| 4898 | IMRN Immuron Limited - American Depositary Shares | 1.22 USD | -0.81% | +5.17% | +5.17% | -32.97% | 7.14 M USD | ||
| 4899 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.66 USD | -5.71% | -10.81% | -14.29% | -39.45% | 7.09 M USD |
Frequently asked questions about Bolt Biotherapeutics, Inc. - Common Stock
What is the Bolt Biotherapeutics, Inc. - Common Stock stock price today?
The current price of Bolt Biotherapeutics, Inc. - Common Stock (BOLT) is 3.7800000000000002. Over the past 24 hours, the stock has changed by 0.00%. Follow the BOLT chart for real-time price dynamics.
What is the stock ticker of Bolt Biotherapeutics, Inc. - Common Stock?
Bolt Biotherapeutics, Inc. - Common Stock trades under the ticker BOLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bolt Biotherapeutics, Inc. - Common Stock stock going up?
BOLT has changed by -8.25% over the last week, -20.25% over the last month, and -36.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Bolt Biotherapeutics, Inc. - Common Stock net income for the last quarter?
Bolt Biotherapeutics, Inc. - Common Stock reported net income of -7.24 M for the last quarter. The previous quarter showed -6.63 M, which means net income changed by -9.24%.
How many employees does Bolt Biotherapeutics, Inc. - Common Stock have?
As of the latest available data, Bolt Biotherapeutics, Inc. - Common Stock has 23 employees. Workforce size can provide additional context about the company's scale and operations.
What is Bolt Biotherapeutics, Inc. - Common Stock EBITDA?
Bolt Biotherapeutics, Inc. - Common Stock EBITDA is -7.4 M, and its EBITDA margin is -28.45 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Bolt Biotherapeutics, Inc. - Common Stock stock?
You can buy Bolt Biotherapeutics, Inc. - Common Stock (BOLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bolt Biotherapeutics, Inc. - Common Stock stock?
Investing in Bolt Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BOLT chart and related analysis on metatrader.com as part of your research.